PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Science Group Team, Tangerang, Indonesia; Pelita Harapan University, Tangerang, Indonesia; Siloam Hospitals, Tangerang, Indonesia; Mochtar Riady Institute of Nanotechnology, Tangerang, Indonesia. Electronic address: antonia.lukito@uph.edu.\', \'Medical Science Group Team, Tangerang, Indonesia; Pelita Harapan University, Tangerang, Indonesia; Siloam Hospitals, Tangerang, Indonesia.\', \'Pelita Harapan University, Tangerang, Indonesia.\', \'Pelita Harapan University, Tangerang, Indonesia; Siloam Hospitals, Tangerang, Indonesia.\', \'Medical Science Group Team, Tangerang, Indonesia; Pelita Harapan University, Tangerang, Indonesia; Mochtar Riady Institute of Nanotechnology, Tangerang, Indonesia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00420-310.1016/j.ijid.2021.05.019
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34038766
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all